Friday, May 25, 2018

Tuesday, 9 October Athens

Panos Kanavos

BSc, MSc (Oxon), MSc (LSE), PhD, Deputy Director, London School of Economics (LSE) Health, Program Director, MSc International Health Policy, LSE Reader in International Health Policy in the Department of Social Policy, London School of Economics (LSE), Program Director of the Medical Technology Research Group (MTRG) at LSE Health

Panos Kanavos
Panos Kanavos

Panos Kanavos (BSc, MSc (Oxon), MSc (LSE), PhD) is Associate Professor in International Health Policy in the Department of Social Policy, London School of Economics (LSE), Deputy Director at LSE Health, and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health. Panos is Visiting Professor at the University of Basel, Switzerland and also has a Visiting appointment with the London School of Hygiene and Tropical Medicine (LSHTM). He has previously been Harkness Fellow in Health Care Policy in the Dept of Ambulatory Care and Prevention, Harvard Medical School. He is an Economist by training, currently coordinates the Programme in International Health Policy at LSE and teaches Health Economics, Pharmaceutical Economics and Policy, Health Care Financing, and Health Systems Performance Measurement.

Panos leads the activities of MTRG, which is a research unit comprising 17 researchers within LSE Health and concentrates on interdisciplinary and comparative policy research on medical technologies. The group has a number of research streams as follows:

  • The economics of medical technologies, in particular, medicines and medical devices;
  • Prescribing, appropriateness and quality of care;
  • Access to medical technologies in developing and transition economies; and
  • Disease management and policy effectiveness in medical technology.

As part of its activities, MTRG administers research initiatives on HTA (, on chronic disease (, runs the Programme on Pharmaceutical Policy Issues (PPPI), the Programme on Medical Devices, conducts research under the auspices of and participates in the European Medicines Information Network (EMI-net), the network for the study of rare diseases (BURQOL-RD), and is a member of the European Health Technology Institute for Socio-Economic Research (EHTI). It also coordinates the activities of The Patient Academy, an initiative between academia, health care regulatory agencies and patient groups.

Panos has acted as an advisor to a number of international governmental and nongovernmental organizations, including the European Commission, the European Parliament, the World Bank, the World Health Organization, the Organization for Economic Co-operation and Development, the American Association for Retired Persons, and Ministries of Health of over 21 transition and developing countries. He has participated in the European Pharmaceutical Forum as advisor to the European Commission – DG Enterprise and has been involved in the Commission's reflection process on the Economics of Medical Devices.

© 2018 Boussias Communications, all rights reserved., T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team